Pelthos Therapeutics Inc. (PTHS AMEX) stock market data APIs
$21.9287
-0.46(-2.1%)
as of September 14, 2026
Try our APIs with
free plan!
Pelthos Therapeutics Inc. Financial Data Overview
Price chart is built with
Anychart
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Prev. Close
21.9287
Open
21.4642
High
22.2803
Low
21.0115
52 wk Range
18.19-37.5
Market Cap
83 997 K
Shares Outstanding
3 828 K
Revenue
43 304 K
EPS
-6.62
Beta
3.047
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Pelthos Therapeutics Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Pelthos Therapeutics Inc. data using free add-ons & libraries
Get Pelthos Therapeutics Inc. Fundamental Data
Pelthos Therapeutics Inc. Fundamental data includes:
- Net Revenue: 43 304 K
- EBITDA: -29 123 000
- Earnings Per Share: -28
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Pelthos Therapeutics Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-13
- EPS/Forecast: -3.02
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Pelthos Therapeutics Inc. News
New
Pelthos Therapeutics Inc. Q2 2026 Earnings Call Summary
Pelthos Therapeutics Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance and Operational Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us ho...
This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
Ligand stock landed in a profit-taking zone Thursday on a strong second-quarter report and an earnings guidance hike. Continue Reading
Why This Biotech Dealmaker — Tied To Merck, Travere — Charged Higher
Ligand stock bounded out of a profit-taking zone Thursday on a strong second-quarter report and an earnings guidance hike. Continue Reading
Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes
DURHAM, N.C., June 30, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet pa...
Get Pelthos Therapeutics Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
